Cargando…

Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients

BACKGROUND: Long-term survival of stage IV melanoma patients has improved significantly with the development of immune checkpoint inhibitors (CIs). Reliable biomarkers to predict response and clinical outcome are needed. METHODS: We investigated the role of melanoma-associated antibodies as predicti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fässler, Mirjam, Diem, Stefan, Mangana, Joanna, Hasan Ali, Omar, Berner, Fiamma, Bomze, David, Ring, Sandra, Niederer, Rebekka, del Carmen Gil Cruz, Cristina, Pérez Shibayama, Christian Ivan, Krolik, Michal, Siano, Marco, Joerger, Markus, Recher, Mike, Risch, Lorenz, Güsewell, Sabine, Risch, Martin, Speiser, Daniel E., Ludewig, Burkhard, Levesque, Mitchell P., Dummer, Reinhard, Flatz, Lukas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383238/ https://www.ncbi.nlm.nih.gov/pubmed/30786924 http://dx.doi.org/10.1186/s40425-019-0523-2

Ejemplares similares

Risk score for non-small cell lung cancer patients starting checkpoint inhibitor treatment
por: Diem, Stefan, et al.
Publicado: (2018)

Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients
por: Purde, Mette-Triin, et al.
Publicado: (2021)

Heterologous Prime Boost Vaccination Induces Protective Melanoma-Specific CD8(+) T Cell Responses
por: Ring, Sandra S., et al.
Publicado: (2020)

Long-term pegylated interferon-α and its potential in the treatment of melanoma
por: Dummer, Reinhard, et al.
Publicado: (2009)

Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients
por: Hasan Ali, Omar, et al.
Publicado: (2020)

Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival
por: Berner, Fiamma, et al.
Publicado: (2021)

Impact of Covid-19 on the management of patients with metastatic melanoma
por: Welti, Michèle, et al.
Publicado: (2022)

Addendum: Impact of Covid-19 on the management of patients with metastatic melanoma
por: Welti, Michèle, et al.
Publicado: (2023)

SENIORLAB: a prospective observational study investigating laboratory parameters and their reference intervals in the elderly
por: Risch, Martin, et al.
Publicado: (2017)

C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer
por: Klümper, Niklas, et al.
Publicado: (2022)

Hair Depigmentation and Hair Loss in Advanced Melanoma Treated with Combined Immunotherapy and Targeted Therapy
por: DIMITRIOU, Florentia, et al.
Publicado: (2020)

Comparison of an automated DNA extraction and 16S rDNA real time PCR/sequencing diagnostic method using optimized reagents with culture during a 15-month study using specimens from sterile body sites
por: Egli, Konrad, et al.
Publicado: (2022)

A new B-Raf inhibitor combo for advanced melanoma
por: Barysch, Marjam-Jeanette, et al.
Publicado: (2018)

Vitamin B12 and folate levels in healthy Swiss senior citizens: a prospective study evaluating reference intervals and decision limits
por: Risch, Martin, et al.
Publicado: (2015)

Clock-like Mutation Signature May Be Prognostic for Worse Survival Than Signatures of UV Damage in Cutaneous Melanoma
por: Fröhlich, Fabienne, et al.
Publicado: (2023)

A consideration of convalescent plasma and plasma derivatives in the care of Severely-ill patients with COVID-19
por: Lung, Thomas, et al.
Publicado: (2020)

Molecular characterization of a ceftriaxone-resistant Neisseria gonorrhoeae strain found in Switzerland: a case report
por: Egli, Konrad, et al.
Publicado: (2021)

Toxicity of combined targeted therapy and concurrent radiotherapy in metastatic melanoma patients: a single-center retrospective analysis
por: Ziegler, Johanna S., et al.
Publicado: (2020)

Association Between Immune-Related Adverse Events During Anti–PD-1 Therapy and Tumor Mutational Burden
por: Bomze, David, et al.
Publicado: (2019)

Inflammation Thread Runs across Medical Laboratory Specialities
por: Nydegger, Urs, et al.
Publicado: (2016)

Comparison of the Diagnostic Performance of qPCR, Sanger Sequencing, and Whole-Genome Sequencing in Determining Clarithromycin and Levofloxacin Resistance in Helicobacter pylori
por: Egli, Konrad, et al.
Publicado: (2020)

Fibroblastic reticular cells at the nexus of innate and adaptive immune responses
por: Perez‐Shibayama, Christian, et al.
Publicado: (2019)

Factors Other than the Glomerular Filtration Rate That Determine the Serum Beta-2-Microglobulin Level
por: Stanga, Zeno, et al.
Publicado: (2013)

Autoimmune diseases - New insights into a troublesome field
por: Lung, Thomas, et al.
Publicado: (2021)

Serum concentrations of 25-hydroxyvitamin D and immunoglobulins in an older Swiss cohort: results of the Senior Labor Study
por: Sakem, Benjamin, et al.
Publicado: (2013)

Osteoporosis, diabetes, and hypertension are major risk factors for mortality in older adults: an intermediate report on a prospective survey of 1467 community-dwelling elderly healthy pensioners in Switzerland
por: Gutzwiller, Jean-Pierre, et al.
Publicado: (2018)

A Longitudinal Analysis of IDO and PDL1 Expression during Immune- or Targeted Therapy in Advanced Melanoma()
por: Krähenbühl, Lukas, et al.
Publicado: (2018)

The role of cyclin D1 and Ki‐67 in the development and prognostication of thin melanoma
por: Kaufmann, Corina, et al.
Publicado: (2020)

Frequency, Treatment and Outcome of Immune-Related Toxicities in Patients with Immune-Checkpoint Inhibitors for Advanced Melanoma: Results from an Institutional Database Analysis
por: Dimitriou, Florentia, et al.
Publicado: (2021)

The complement system in liver diseases: Evidence-based approach and therapeutic options()
por: Lung, Thomas, et al.
Publicado: (2019)

Reference Intervals for Platelet Counts in the Elderly: Results from the Prospective SENIORLAB Study
por: Hermann, Wolfgang, et al.
Publicado: (2020)

Mortality risk factors in community-dwelling, subjectively healthy, Swiss older adults: update after 8-years follow-up
por: Gutzwiller, Jean-Pierre, et al.
Publicado: (2023)

Diffuse Cutaneous Melanosis Associated with Malignant Melanoma
por: Mangana, Joanna, et al.
Publicado: (2015)

Design and Validation of a Sensitive Multisteroid LC-MS/MS Assay for the Routine Clinical Use: One-Step Sample Preparation with Phospholipid Removal and Comparison to Immunoassays
por: Braun, Valentin, et al.
Publicado: (2022)

The Association of suPAR with Cardiovascular Risk Factors in Young and Healthy Adults
por: Wohlwend, Niklas Fabio, et al.
Publicado: (2023)

How I treat metastatic melanoma
por: Dummer, Reinhard, et al.
Publicado: (2019)

Standardized diagnostic algorithm for spitzoid lesions aids clinical decision-making and management: a case series from a Swiss reference center
por: Hilbers, Marie-Luise, et al.
Publicado: (2021)

Addendum: Standardized diagnostic algorithm for spitzoid lesions aids clinical decision-making and management: a case series from a Swiss reference center
por: Hilbers, Marie-Luise, et al.
Publicado: (2022)

Diagnostic Accuracy of Holotranscobalamin, Vitamin B12, Methylmalonic Acid, and Homocysteine in Detecting B12 Deficiency in a Large, Mixed Patient Population
por: Jarquin Campos, Araceli, et al.
Publicado: (2020)

Concentrations of Serum Brain Injury Biomarkers Following SARS-CoV-2 Infection in Individuals with and without Long-COVID—Results from the Prospective Population-Based COVI-GAPP Study
por: Telser, Julia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7glt5uad53k47l4m4bnlq34e7d